1084953-18-3

Basic information

• Product Name: methyl 4-bromo-5-fluoro-2-methoxybenzoate
• Synonyms: methyl 4-bromo-5-fluoro-2-methoxybenzoate
• CAS NO: 1084953-18-3
• Molecular Formula: C9H8BrFO3
• Molecular Weight: 263.063
• Mol File: 1084953-18-3.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: methyl 4-bromo-5-fluoro-2-methoxybenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-bromo-5-fluoro-2-methoxybenzoate(1084953-18-3)
• EPA Substance Registry System: methyl 4-bromo-5-fluoro-2-methoxybenzoate(1084953-18-3)

Safety Data

• Hazardous Substances Data: 1084953-18-3(Hazardous Substances Data)

Upstream product

• 886510-25-4 4-bromo-5-fluoro-2-methoxyphenol 
• 67-56-1 methanol 
• 28314-82-1 4-bromo-2,5-difluorobenzoic acid 
• 327-51-5 1,4-dibromo-2,5-difluorobenzene 
• 1193162-21-8 4-bromo-2,5-difluoro-benzoic acid methyl ester 
• 124-41-4 sodium methylate 
• 1084953-17-2 trifluoromethanesulfonic acid 4-bromo-5-fluoro-2-methoxyphenyl ester 
• 201230-82-2 carbon monoxide 

Downstream Products

• 1780187-45-2 4-bromo-5-fluoro-2-methoxybenzoic acid 

Relevant articles and documents

In vitro and in vivo identification of novel positive allosteric modulators of the human dopamine D2 and D3 receptor

Agonists at dopamine D2 and D3 receptors are important therapeutic agents in the treatment of Parkinson's disease. Compared with the use of agonists, allosteric potentiators offer potential advantages such as temporal, regional, and phasic potentiation of

4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORGAMMAT INHIBITORS AND USES THEREOF

Provided are compounds according to Formula I or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

RORGAMMAT INHIBITORS

The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or condition.